News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

News

Apricorn Enhances Aegis Secure Key 3.0 with Performance, Capacity and Environmental Protection Advancements

May 13, 2026 SDBN Comments Off on Apricorn Enhances Aegis Secure Key 3.0 with Performance, Capacity and Environmental Protection Advancements

Product submitted to NIST CMVP for FIPS 140-3 Level 3 validation POWAY, Calif. and SAN DIEGO, May 13, 2026 /PRNewswire/ — Apricorn, the leading global provider of quantum-resistant hardware-encrypted external storage solutions, today announced significant […]

No Picture
News

Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy

May 13, 2026 SDBN Comments Off on Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy

Phase 2b study design to be discussed at BIO International Convention in San Diego as Can-Fite advances partnership negotiations with leading oncology companies Click here to view original post Click Here to Publish/Feature Your Company […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026 SDBN Comments Off on Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today reported its first quarter 2026 financial […]

No Picture
News

UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

May 12, 2026 SDBN Comments Off on UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Accord Asset Partners Announces the Completion of Palladium Equity’s Previously Announced Purchase of Majority Stake in DME Express

May 12, 2026 SDBN Comments Off on Accord Asset Partners Announces the Completion of Palladium Equity’s Previously Announced Purchase of Majority Stake in DME Express

SAN DIEGO and THE WOODLANDS, Texas, May 12, 2026 /PRNewswire/ — Accord Asset Partners (along with its affiliates, “Accord”) announces the sale of a majority equity interest in DME Express (“DME Express” or the “Company”), […]


ADVERTISEMENT — Advertise With Biotech Networks
News

CliniComp Named “Best Overall EHR Solution Provider” in 10th Annual MedTech Breakthrough Awards Program

May 12, 2026 SDBN Comments Off on CliniComp Named “Best Overall EHR Solution Provider” in 10th Annual MedTech Breakthrough Awards Program

EHR leader honored for third consecutive year among trailblazers in digital health and medical technology industry SAN DIEGO, May 12, 2026 /PRNewswire/ — CliniComp, a pioneer in high-performing, reliable, electronic health record (EHR) solutions, today […]

News

Anaergia’s Rhode Island Bioenergy Facility Receives Temporary Negative Carbon Intensity Score Approval Under Canada’s Clean Fuel Regulations

May 12, 2026 SDBN Comments Off on Anaergia’s Rhode Island Bioenergy Facility Receives Temporary Negative Carbon Intensity Score Approval Under Canada’s Clean Fuel Regulations

CARLSBAD, California & BURLINGTON, Ontario–(BUSINESS WIRE)–The Rhode Island Bioenergy Facility (“RIBF”), owned and operated by a subsidiary of Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) (OTCQX: ANRGF), has received a temporary negative Carbon Intensity […]

News

UC San Diego Team Launches Free ‘Digital Twin’ for End-to-End Testing of Applications over Wireless

May 12, 2026 SDBN Comments Off on UC San Diego Team Launches Free ‘Digital Twin’ for End-to-End Testing of Applications over Wireless

UC San Diego engineers created a free, open-source “digital twin” that simulates real-world wireless networks, giving researchers and startups a faster, more accessible way to test next-generation technologies. Click here to view original post Click […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference

May 11, 2026 SDBN Comments Off on Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference

SAN DIEGO–(BUSINESS WIRE)–Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced two scientific posters for its […]

News

Could Hantavirus Spread Like COVID-19?

May 11, 2026 SDBN Comments Off on Could Hantavirus Spread Like COVID-19?

The outbreak tied to the cruise ship MV Hondius has stirred memories of the early days of COVID-19. An epidemiologist from the Herbert Wertheim School of Public Health and Human Longevity Science breaks down what […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Actio Biosciences Announces Initiation of KYRON Phase 1b/2 Trial of ABS-1230 for the Treatment of KCNT1-Related Epilepsy and Acceptance into FDA’s Rare Disease Evidence Principles Process

May 8, 2026 SDBN Comments Off on Actio Biosciences Announces Initiation of KYRON Phase 1b/2 Trial of ABS-1230 for the Treatment of KCNT1-Related Epilepsy and Acceptance into FDA’s Rare Disease Evidence Principles Process

SAN DIEGO–(BUSINESS WIRE)–Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel precision medicines, today announced the initiation of the KYRON Phase 1b/2 clinical trial of ABS-1230 for the treatment of […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Maravai LifeSciences Reports First Quarter 2026 Financial Results

May 7, 2026 SDBN Comments Off on Maravai LifeSciences Reports First Quarter 2026 Financial Results

SAN DIEGO–(BUSINESS WIRE)–Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2026, […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Ian Guldner joins Salk Institute to advance foundational research on brain aging and Alzheimer’s disease

May 7, 2026 SDBN Comments Off on Ian Guldner joins Salk Institute to advance foundational research on brain aging and Alzheimer’s disease

Highlights Salk has recruited Ian Guldner as a new assistant professor, bringing fresh momentum to foundational research on Alzheimer’s disease and related dementias Guldner’s lab will identify cellular communication mechanisms that regulate brain aging and […]

News

ChiroTouch Wins Practice Management Innovation Award in 10th Annual MedTech Breakthrough Awards Program

May 7, 2026 SDBN Comments Off on ChiroTouch Wins Practice Management Innovation Award in 10th Annual MedTech Breakthrough Awards Program

Chiropractic EHR developer earns accolade for creating first AI agent purpose-built for chiropractors SAN DIEGO, May 7, 2026 /PRNewswire/ — ChiroTouch, the leading chiropractic EHR and practice management solution, today announced that it has been […]